Spain · Delayed Price · Currency is EUR BME:REN Statistics
Total Valuation
BME:REN has a market cap or net worth of EUR 24.16 million. The enterprise value is 37.13 million.
| Market Cap | 24.16M |
| Enterprise Value | 37.13M |
Important Dates
The next estimated earnings date is Friday, October 24, 2025.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:REN has 32.37 million shares outstanding.
| Current Share Class | 32.37M |
| Shares Outstanding | 32.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.75% |
| Owned by Institutions (%) | 4.55% |
| Float | 17.89M |
Valuation Ratios
The trailing PE ratio is 4.70.
| PE Ratio | 4.70 |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | 5.47 |
| P/OCF Ratio | 4.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.16, with an EV/FCF ratio of 8.40.
| EV / Earnings | 7.22 |
| EV / Sales | 1.23 |
| EV / EBITDA | 85.16 |
| EV / EBIT | n/a |
| EV / FCF | 8.40 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.70 |
| Quick Ratio | 0.25 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.71 |
| Interest Coverage | -0.83 |
Financial Efficiency
Return on equity (ROE) is 9.66% and return on invested capital (ROIC) is -1.11%.
| Return on Equity (ROE) | 9.66% |
| Return on Assets (ROA) | -1.01% |
| Return on Invested Capital (ROIC) | -1.11% |
| Return on Capital Employed (ROCE) | -2.41% |
| Revenue Per Employee | 837,944 |
| Profits Per Employee | 142,889 |
| Employee Count | 43 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.62 |
Taxes
| Income Tax | -346,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.34% in the last 52 weeks. The beta is 0.95, so BME:REN's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -1.34% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 44.62 |
| Average Volume (20 Days) | 25,939 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:REN had revenue of EUR 30.17 million and earned 5.14 million in profits.
| Revenue | 30.17M |
| Gross Profit | 14.47M |
| Operating Income | -1.57M |
| Pretax Income | 5.59M |
| Net Income | 5.14M |
| EBITDA | -1.34M |
| EBIT | -1.57M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 3.43 million in cash and 16.40 million in debt, giving a net cash position of -12.97 million or -0.40 per share.
| Cash & Cash Equivalents | 3.43M |
| Total Debt | 16.40M |
| Net Cash | -12.97M |
| Net Cash Per Share | -0.40 |
| Equity (Book Value) | 63.43M |
| Book Value Per Share | n/a |
| Working Capital | 13.42M |
Cash Flow
In the last 12 months, operating cash flow was 6.02 million and capital expenditures -1.60 million, giving a free cash flow of 4.42 million.
| Operating Cash Flow | 6.02M |
| Capital Expenditures | -1.60M |
| Free Cash Flow | 4.42M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 47.98%, with operating and profit margins of -5.20% and 17.05%.
| Gross Margin | 47.98% |
| Operating Margin | -5.20% |
| Pretax Margin | 18.52% |
| Profit Margin | 17.05% |
| EBITDA Margin | -4.43% |
| EBIT Margin | -5.20% |
| FCF Margin | 14.65% |
Dividends & Yields
BME:REN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 21.29% |
| FCF Yield | 18.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:REN has an Altman Z-Score of -0.07 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.07 |
| Piotroski F-Score | 7 |